Alunbrig Market

Alunbrig is a cancer medicine that is used to treat adults with a type of lung cancer called non-small cell lung cancer (NSCLC) who have been treated before with a cancer medicine called crizotinib.
Alunbrig Market contains market size and forecasts of Alunbrig in global, including the following market information:
Global Alunbrig Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Alunbrig Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Alunbrig companies in 2021 (%)
The global Alunbrig market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
30mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Alunbrig include ARIAD Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Alunbrig manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alunbrig Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Alunbrig Market Segment Percentages, by Type, 2021 (%)

• 30mg
• 50mg
• 180mg

• Hospital
• Pharmacy

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

• Key companies Alunbrig revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Alunbrig revenues share in global market, 2021 (%)
• Key companies Alunbrig sales in global market, 2017-2022 (Estimated), (K MT)
• Key companies Alunbrig sales share in global market, 2021 (%)

• ARIAD Pharmaceuticals